Joanna S. Fowler

Joanna S. Fowler

Auto-generated profile, based on publicly available information

Joanna S. Fowler

Brookhaven National Laboratory

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2008 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
NANelly Alia-Klein
Nelly Alia-Klein
RGRita Z. Goldstein
Rita Z. Goldstein
AKAarti Kriplani
Aarti Kriplani
JLJean Logan
Jean Logan
DTDardo Tomasi
Dardo Tomasi
JFJoanna S. Fowler
Joanna S. Fowler
The genetic deletion of monoamine oxidase A (MAO A), an enzyme that breaks down the monoamine neurotransmitters norepinephrine, serotonin, and dopamine, produces aggressive phenotypes across species. Therefore, a common polymorphism in the MAO A gene (MAOA, Mendelian Inheritance in Men database number 309850, referred to as high or low based on transcription in non-neuronal cells) has been investigated in a number of externalizing behavioral and clinical phenotypes. These studies provide evidence linking the low MAOA genotype and violent behavior but only through interaction with severe environmental stressors during childhood. Here, we hypothesized that in healthy adult males the gene product of MAO A in the brain, rather than the gene per se, would be associated with regulating the concentration of brain amines involved in trait aggression. Brain MAO A activity was measuredin vivoin healthy nonsmoking men with positron emission tomography using a radioligand specific for MAO A (clorgyline labeled with carbon 11). Trait aggression was measured with the multidimensional personality questionnaire (MPQ). Here we report for the first time that brain MAO A correlates inversely with the MPQ trait measure of aggression (but not with other personality traits) such that the lower the MAO A activity in cortical and subcortical brain regions, the higher the self-reported aggression (in both MAOA genotype groups) contributing to more than one-third of the variability. Because trait aggression is a measure used to predict antisocial behavior, these results underscore the relevance of MAO A as a neurochemical substrate of aberrant aggression.

14 July 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NVNora D Volkow
Nora D Volkow
GWGene-Jack Wang
Gene-Jack Wang
FTFrank Telang
Frank Telang
JFJoanna S. Fowler
Joanna S. Fowler
DADavid Alexoff
David Alexoff
DTDardo Tomasi
Dardo Tomasi
Moves to legalize marijuana highlight the urgency to investigate effects of chronic marijuana in the human brain. Here, we challenged 48 participants (24 controls and 24 marijuana abusers) with methylphenidate (MP), a drug that elevates extracellular dopamine (DA) as a surrogate for probing the reactivity of the brain to DA stimulation. We compared the subjective, cardiovascular, and brain DA responses (measured with PET and [11C]raclopride) to MP between controls and marijuana abusers. Although baseline (placebo) measures of striatal DA D2 receptor availability did not differ between groups, the marijuana abusers showed markedly blunted responses when challenged with MP. Specifically, compared with controls, marijuana abusers had significantly attenuated behavioral (“self-reports” for high, drug effects, anxiety, and restlessness), cardiovascular (pulse rate and diastolic blood pressure), and brain DA [reduced decreases in distribution volumes (DVs) of [11C]raclopride, although normal reductions in striatal nondisplaceable binding potential (BPND)] responses to MP. In ventral striatum (key brain reward region), MP-induced reductions in DVs and BPND (reflecting DA increases) were inversely correlated with scores of negative emotionality, which were significantly higher for marijuana abusers than controls. In marijuana abusers, DA responses in ventral striatum were also inversely correlated with addiction severity and craving. The attenuated responses to MP, including reduced decreases in striatal DVs, are consistent with decreased brain reactivity to the DA stimulation in marijuana abusers that might contribute to their negative emotionality (increased stress reactivity and irritability) and addictive behaviors. Significance Marijuana abusers show lower positive and higher negative emotionality scores than controls, which is consistent, on one hand, with lower reward sensitivity and motivation and, on the other hand, with increased stress reactivity and irritability. To investigate this aspect of marijuana’s impact on the human brain, we compared the brain’s reactivity in marijuana abusers vs. controls when challenged with methylphenidate (MP). We found that marijuana abusers display attenuated dopamine (DA) responses to MP, including reduced decreases in striatal distribution volumes. These deficits cannot be unambiguously ascribed to reduced DA release (because decreases in nondisplaceable binding potential were not blunted) but could reflect a downstream postsynaptic effect that in the ventral striatum (brain reward region) might contribute to marijuana’s negative emotionality and addictive behaviors.

1 January 2003 in NeuroToxicology
Verified
Journal Article
Closed access
JFJoanna S. Fowler
Joanna S. Fowler
JLJean Logan
Jean Logan
GWGene-Jack Wang
Gene-Jack Wang
NVNora D. Volkow
Nora D. Volkow

1 April 2007 in Science & Practice Perspectives
Verified
Journal Article
Closed access
JFJoanna Fowler
Joanna Fowler
NVNora Volkow
Nora Volkow
CKCheryl Kassed
Cheryl Kassed
LCLinda Chang
Linda Chang
Modern imaging techniques enable researchers to observe drug actions and consequences as they occur and persist in the brains of abusing and addicted individuals. This article presents the five most commonly used techniques, explains how each produces images, and describes how researchers interpret them. The authors give examples of key findings illustrating how each technique has extended and deepened our knowledge of the neurobiological bases of drug abuse and addiction, and they address potential clinical and therapeutic applications.

1 August 2007 in Biological Psychiatry
Verified
Journal Article
Closed access
JFJoanna S. Fowler
Joanna S. Fowler
NANelly Alia-Klein
Nelly Alia-Klein
AKAarti Kriplani
Aarti Kriplani
JLJean Logan
Jean Logan
BWBenjamin Williams
Benjamin Williams
GWGene-Jack Wang
Gene-Jack Wang

1 December 2008 in NeuroImage
Verified
Journal Article
Closed access
JFJoanna S. Fowler
Joanna S. Fowler
NVNora D. Volkow
Nora D. Volkow
JLJean Logan
Jean Logan
DADavid Alexoff
David Alexoff
FTFrank Telang
Frank Telang
KAKaren Apelskog
Karen Apelskog